Kiniksa Pharmaceuticals International Plc (KNSA)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Kiniksa Pharmaceuticals International Plc-Aktie (KNSA)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	11.76% 202.13	180.85	156.80	137.78	122.54
Cost Of Revenue	3.40% 20.95	20.26	18.60	17.87	17.90
Gross Profit	12.82% 181.18	160.60	138.19	119.92	104.64
Operating Expenses	18.19% 161.41	136.58	118.03	106.64	123.94
Benefits Costs and Expenses	16.37% 178.86	153.70	133.92	122.22	139.51
Costs And Expenses	16.37% 178.86	153.70	133.92	122.22	139.51
Depreciation and Amortization	21.61% 0.467	0.384	0.358	0.345	0.40
Operating Income/Loss	17.71% 19.77	24.02	20.16	13.27	-19.30
Income/Loss From Continuing Operations Before Tax	14.32% 23.27	27.16	22.88	15.56	-16.98
Income Tax Expense/Benefit, Deferred	25.76% 3.138	4.227	2.644	2.993	-3.163
Income Tax Expense/Benefit	3.99% 9.07	8.722	5.045	7.026	-8.091
Income/Loss From Continuing Operations After Tax	22.98% 14.20	18.43	17.83	8.539	-8.888
Net Income/Loss	22.98% 14.20	18.43	17.83	8.539	-8.888
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	99.20% 0.5952	74.71	73.44	72.65	0.3005
Diluted Average Shares	98.81% 0.9517	80.04	77.94	76.15	0.3005
Basic Earnings Per Share	24.00% 0.19	0.25	0.24	0.12	-0.12
Diluted Earnings Per Share	21.74% 0.18	0.23	0.23	0.11	-0.12
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-